Antidepressant medications and osteoporosis

Antidepressant medications and osteoporosis

Use of antidepressant medications that act on the serotonin system has been linked to detrimental impacts on bone mineral density (BMD), and to osteoporosis. This article reviews current evidence for such effects, and identifies themes for future research. Serotonin receptors are found in all major...

Description complète

Détails bibliographiques
Auteurs principaux:	Rizzoli, R, Cooper, C, Reginster, J, Abrahamsen, B, Adachi, J, Brandi, M, Bruyère, O, Compston, J, Ducy, P, Ferrari, S, Harvey, N, Kanis, J, Karsenty, G, Laslop, A, Rabenda, V, Vestergaard, P
Format:	Journal article
Publié:	2012

Documents similaires

Partial adherence: a new perspective on health economic assessment in osteoporosis.
par: Kanis, J, et autres
Publié: (2011)

A reappraisal of generic bisphosphonates in osteoporosis.
par: Kanis, J, et autres
Publié: (2012)

Management of glucocorticoid-induced osteoporosis.
par: Rizzoli, R, et autres
Publié: (2012)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
par: Rizzoli, R, et autres
Publié: (2013)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
par: Delmas, P, et autres
Publié: (2005)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
par: Kanis, J, et autres
Publié: (2008)

Health technology assessment in osteoporosis.
par: Hiligsmann, M, et autres
Publié: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
par: Kanis, J, et autres
Publié: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
par: Kanis, J, et autres
Publié: (2013)

The International Osteoporosis Foundation: history, objectives and achievements.
par: Cooper, C, et autres
Publié: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
par: Cooper, C, et autres
Publié: (2009)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
par: Cooper, C, et autres
Publié: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
par: Kanis, J, et autres
Publié: (2008)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
par: Rizzoli, R, et autres
Publié: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
par: Rizzoli, R, et autres
Publié: (2011)

Management of osteoporosis of the oldest old (vol 25, pg 2507, 2014)
par: Rizzoli, R, et autres
Publié: (2014)

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
par: Bruyère, O, et autres
Publié: (2014)

Challenges for the development of bone-forming agents in Europe
par: Kanis, J, et autres
Publié: (2014)

Challenges for the development of bone-forming agents in Europe.
par: Kanis, J, et autres
Publié: (2014)

The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
par: Harvey, N, et autres
Publié: (2016)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
par: Rizzoli, R, et autres
Publié: (2011)

Treatment of osteoporosis in men.
par: Kaufman, J, et autres
Publié: (2013)

Modelling cost-effectiveness in osteoporosis
par: Kanis, J, et autres
Publié: (2008)

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
par: Rizzoli, R, et autres
Publié: (2014)

DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS
par: Gauthier, A, et autres
Publié: (2009)

The cost-effectiveness of alendronate in the management of osteoporosis.
par: Kanis, J, et autres
Publié: (2008)

Assessment of cardiovascular safety of anti-osteoporosis drugs
par: Fuggle, NR, et autres
Publié: (2020)

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
par: Hiligsmann, M, et autres
Publié: (2013)

Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years.
par: Bruyere, O, et autres
Publié: (2013)

CHANGES IN THE STRUCTURE AND THE SYMPTOMS OF THE OSTEOARTHRITIC KNEE AND PREDICTION OF FUTURE KNEE REPLACEMENT OVER AN 8-YEAR FOLLOW-UP PERIOD
par: Bruyere, O, et autres
Publié: (2013)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.
par: Compston, J, et autres
Publié: (2013)

Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art
par: Fuggle, NR, et autres
Publié: (2024)

Development and validation of a disease model for postmenopausal osteoporosis.
par: Gauthier, A, et autres
Publié: (2011)

Fracture risk following intermission of osteoporosis therapy
par: Dennison, EM, et autres
Publié: (2019)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
par: Kanis, J, et autres
Publié: (1997)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
par: Bruyère, O, et autres
Publié: (2008)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
par: Ström, O, et autres
Publié: (2011)

DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS
par: Gauthier, A, et autres
Publié: (2010)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (vol 75, pg 392, 2013)
par: Compston, J, et autres
Publié: (2013)

Erratum: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (Maturitas (2013) 75 (392-396))
par: Compston, J, et autres
Publié: (2013)